A Long-Term Extension Study To Evaluate The Safety Of Filgotinib In Subjects With Crohns Disease.
Principal Investigator(s)
Email for information
Funded by
Geneva
Research Start Date
Status
Active
This is a long-term extension study to evaluate the safety of filgotinib administered to subjects with Crohns Disease (CD).
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.